Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (571-580 of 599) with videos related to

Pageof 60
Sort By:
ACS Pharmacology & Translational Science|March 17, 2023
Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their ProdrugsJung-Eun Park, Hobin Lee, Paola Oliva, et al.
The Journal of Clinical Investigation|February 23, 2021
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10Mariaconcetta Durante, Silvia Squillace, Filomena Lauro, et al.
Journal of Medicinal Chemistry|August 17, 2022
GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A<sub>2A</sub> Adenosine ReceptorAnna Shiriaeva, Daejin Park, Gyudong Kim, et al.
Journal of Medicinal Chemistry|January 6, 2006
Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptorLak Shin Jeong, Hyuk Woo Lee, Kenneth A Jacobson, et al.
Journal of Medicinal Chemistry|February 3, 2022
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y<sub>14</sub>R AntagonistZhiwei Wen, Veronica Salmaso, Young-Hwan Jung, et al.
Journal of Medicinal Chemistry|June 29, 2023
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y<sub>14</sub> Receptor AntagonistsZhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Journal of Medicinal Chemistry|January 4, 2019
Design and in Vivo Characterization of A<sub>1</sub> Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba SeriesDilip K Tosh, Harsha Rao, Amelia Bitant, et al.
Bioorganic & Medicinal Chemistry|April 11, 2006
Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptorLak Shin Jeong, Hyuk Woo Lee, Hea Ok Kim, et al.
Nature|March 31, 2015
Two disparate ligand-binding sites in the human P2Y1 receptorDandan Zhang, Zhan-Guo Gao, Kaihua Zhang, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Development and Preclinical Evaluation of PET Radiotracers Targeting Adenosine A<sub>1</sub> ReceptorsAbolghasem Gus Bakhoda, Torben D Pearson, Zhan-Guo Gao, et al.
Pageof 60

Showing results (571-580 of 599) with videos related to

Sort By:
Pageof 60
ACS Pharmacology & Translational Science|March 17, 2023
Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their ProdrugsJung-Eun Park, Hobin Lee, Paola Oliva, et al.
The Journal of Clinical Investigation|February 23, 2021
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10Mariaconcetta Durante, Silvia Squillace, Filomena Lauro, et al.
Journal of Medicinal Chemistry|August 17, 2022
GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A<sub>2A</sub> Adenosine ReceptorAnna Shiriaeva, Daejin Park, Gyudong Kim, et al.
Journal of Medicinal Chemistry|January 6, 2006
Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptorLak Shin Jeong, Hyuk Woo Lee, Kenneth A Jacobson, et al.
Journal of Medicinal Chemistry|February 3, 2022
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y<sub>14</sub>R AntagonistZhiwei Wen, Veronica Salmaso, Young-Hwan Jung, et al.
Journal of Medicinal Chemistry|June 29, 2023
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y<sub>14</sub> Receptor AntagonistsZhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Journal of Medicinal Chemistry|January 4, 2019
Design and in Vivo Characterization of A<sub>1</sub> Adenosine Receptor Agonists in the Native Ribose and Conformationally Constrained (N)-Methanocarba SeriesDilip K Tosh, Harsha Rao, Amelia Bitant, et al.
Bioorganic & Medicinal Chemistry|April 11, 2006
Design, synthesis, and biological activity of N6-substituted-4'-thioadenosines at the human A3 adenosine receptorLak Shin Jeong, Hyuk Woo Lee, Hea Ok Kim, et al.
Nature|March 31, 2015
Two disparate ligand-binding sites in the human P2Y1 receptorDandan Zhang, Zhan-Guo Gao, Kaihua Zhang, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Development and Preclinical Evaluation of PET Radiotracers Targeting Adenosine A<sub>1</sub> ReceptorsAbolghasem Gus Bakhoda, Torben D Pearson, Zhan-Guo Gao, et al.
Pageof 60